Merck Sues Xellia Over Plan For Generic Anti-Fungal Drug
Merck Sharp & Dohme Corp. targeted drug manufacturer Xellia Pharmaceuticals ApS with a lawsuit in Delaware federal court on Friday, alleging that the generics company's proposed version of the anti-fungal medication...To view the full article, register now.
Already a subscriber? Click here to view full article